Full Press Release Details
Immutep Announces Publication of Abstracts at ESMO Congress 2023.
IMMP
Immutep Announces Publication of Abstracts at ESMO Congress 2023
Key Takeaway: Immutep Announces Publication of Abstracts at ESMO Congress 2023
Price reaction · baseline $1.84 (2023-10-13 close) · 1 other IMMP headline(s) in the window, move may be shared
day 0 close
-1.1%
day 1
-0.5%
day 3
+0.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)